Breye Therapeutics
Breye Therapeutics develops oral medicines for retinal diseases.
€67.5MSeries A
ParticipantMV
Modi Ventures
Activity from announced rounds
All recorded activity
- Rounds participated in
- 6
- Confirmed lead rounds
- 0 5 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $520.3M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in all activityLatus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedEridu
Develops purpose-built networking silicon and systems for AI data centers and hyperscalers
$200MSeries A
Role not disclosedBrainomix
Develops AI-powered imaging tools for stroke and lung fibrosis
$6.8MSeries C+
Role not disclosedExciva
Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease
€51MSeries B
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed